Evaluation of severe neutropenia and diarrhea in Asian cancer patients receiving UGT1A1 genotype-guided irinotecan dosing.

被引：0
|
作者：
Sutiman, Natalia
Ramasamy, Saminathan
Ng, Chau Hsien Matthew
Choo, SuPin
Wenrui, Rachel Lim
Ling, Clarinda Chua Wei
Kuang, John Chia Whay
Tan, Iain B.
Chowbay, Balram
机构：
[1] SingHlth Clin Pharmacol, Singapore, Singapore
[2] Natl Canc Ctr, Div Med Sci, Clin Pharmacol Lab, Singapore, Singapore
[3] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e13572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13572
引用
收藏
页数：1
相关论文
共 50 条
  • [1] UGT1A1 genotype-guided dosing of irinotecan: time to prioritize patient safety
    Peeters, Sofia L. J.
    Deenen, Maarten J.
    Thijs, Anna M. J.
    Hulshof, Emma C.
    Mathijssen, Ron H. J.
    Gelderblom, Hans
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    PHARMACOGENOMICS, 2023, 24 (09) : 435 - 439
  • [2] Safety and pharmacokinetic analysis of UGT1A1 genotype-guided dosing of irinotecan.
    Hulshof, Emma C.
    de With, Mirjam
    de Man, Femke M.
    Creemers, Geert-Jan
    Deiman, Birgit A. L. M.
    Swen, Jesse J.
    Houterman, Saskia
    Koolen, Stijn L. W.
    Laven, Marjan
    Luelmo, Saskia
    van Schaik, Ron H. N.
    Guchelaar, Henk-jan
    Mathijssen, Ron H. J.
    Gelderblom, Hans
    Deenen, Maarten J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
    Hulshof, Emma C.
    de With, Mirjam
    de Man, Femke M.
    Creemers, Geert-Jan
    Deiman, Birgit A. L. M.
    Swen, Jesse J.
    Houterman, Saskia
    Koolen, Stijn L. W.
    Bins, Sander
    Thijs, Anna M. J.
    Laven, Marjan M. J.
    Hovels, Anke M.
    Luelmo, Saskia A. C.
    Houtsma, Danny
    Shulman, Katerina
    McLeod, Howard L.
    van Schaik, Ron H. N.
    Guchelaar, Henk-Jan
    Mathijssen, Ron H. J.
    Gelderblom, Hans
    Deenen, Maarten J.
    EUROPEAN JOURNAL OF CANCER, 2022, 162 : 148 - 157
  • [4] UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine
    Matthew P. Goetz
    Heidi A. McKean
    Joel M. Reid
    Sumithra J. Mandrekar
    Angelina D. Tan
    Mary A. Kuffel
    Stephanie L. Safgren
    Renee M. McGovern
    Richard M. Goldberg
    Axel A. Grothey
    Robert McWilliams
    Charles Erlichman
    Matthew M. Ames
    Investigational New Drugs, 2013, 31 : 1559 - 1567
  • [5] The impact of UGT1A1*28 and UGT1A1*6 on irinotecan-induced neutropenia in Asian cancer patients receiving weekly and three weekly irinotecan regimens
    Chowbay, B.
    Rao, S. J. Srinivasa Jada
    Cher, B. C. Goh Boon
    Lim, R. Robert
    Teck, W. T. Lim Wan
    Huat, E. H. Tan Eng
    EJC SUPPLEMENTS, 2006, 4 (12): : 136 - 136
  • [6] Re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients Is it time for everyone treated with irinotecan to be tested for UGT1A1 gene polymorphism?
    Kong, Lingti
    Rong, Li
    Wang, Muhua
    EUROPEAN JOURNAL OF CANCER, 2022, 170 : 194 - 195
  • [7] UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine
    Goetz, Matthew P.
    McKean, Heidi A.
    Reid, Joel M.
    Mandrekar, Sumithra J.
    Tan, Angelina D.
    Kuffel, Mary A.
    Safgren, Stephanie L.
    McGovern, Renee M.
    Goldberg, Richard M.
    Grothey, Axel A.
    McWilliams, Robert
    Erlichman, Charles
    Ames, Matthew M.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1559 - 1567
  • [8] Towards UGT1A1 guided irinotecan dosing
    Hicks, J. Kevin
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 (09) : 980 - 981
  • [9] Towards UGT1A1 guided irinotecan dosing
    J. Kevin Hicks
    European Journal of Human Genetics, 2023, 31 : 980 - 981
  • [10] A UGT1A1 genotype-guided dosing study of irinotecan in metastatic colorectal cancer (mCRC) patients (pts) treated with FOLFIRI plus bevacizumab (BEV).
    Sharma, Manish
    Toffoli, Giuseppe
    Buonadonna, Angela
    Marangon, Elena
    Polite, Blase N.
    Frustaci, Sergio
    Innocenti, Federico
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345